ES2145971T3 - Procedimiento de preparacion de un cetal derivado de esteroide. - Google Patents

Procedimiento de preparacion de un cetal derivado de esteroide.

Info

Publication number
ES2145971T3
ES2145971T3 ES96203367T ES96203367T ES2145971T3 ES 2145971 T3 ES2145971 T3 ES 2145971T3 ES 96203367 T ES96203367 T ES 96203367T ES 96203367 T ES96203367 T ES 96203367T ES 2145971 T3 ES2145971 T3 ES 2145971T3
Authority
ES
Spain
Prior art keywords
sub
cetal
steroid
preparation
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96203367T
Other languages
English (en)
Inventor
Franciscus Theodorus Le Brands
Pieter Vrijhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2145971T3 publication Critical patent/ES2145971T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Abstract

LA PRESENTE INVENCION SE RELACIONA CON UN METODO DE PREPARACION DE UN DERIVADO CETAL DE UN ESTEROIDE, DE ACUERDO CON LA FORMULA GENERAL I: DONDE R{SUB,1} ES CH{SUB,3} O C{SUB,2}H{SUB,5}; R{SUB,2} ES OH; R{SUB,3} ES H, CH{SUB,3}; C=CH, CH{SUB,2}HAL, O CH{SUB,2}CN; O R{SUB,2} Y R{SUB,3} UNIDOS SON O; R{SUB,4} ES (2-5C) ALQUILENO; Y HAL ES CL, BR O I, CARACTERIZADO POR QUE EL COMPUESTO DE FORMULA II: DONDE R{SUB,1}, R{SUB,2} Y R{SUB,3} TIENEN LOS SIGNIFICADOS PREVIAMENTE INDICADOS, SE TRATA EN PRESENCIA DE UN ORTOESTER DE FORMULA III: O DE UN ORTOESTER DE FORMULA IV: DONDE R{SUB,4} TIENE EL SIGNIFICADO PREVIAMENTE INDICADO, O UNA MEZCLA DE LOS MISMOS CON UN ALCOHOL DE FORMULA GENERAL HOR{SUB,4}OH, DONDE R{SUB,4} TIENE EL SIGNIFICADO PREVIAMENTE INDICADO.
ES96203367T 1995-11-30 1996-11-28 Procedimiento de preparacion de un cetal derivado de esteroide. Expired - Lifetime ES2145971T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1001787 1995-11-30

Publications (1)

Publication Number Publication Date
ES2145971T3 true ES2145971T3 (es) 2000-07-16

Family

ID=19761947

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96203367T Expired - Lifetime ES2145971T3 (es) 1995-11-30 1996-11-28 Procedimiento de preparacion de un cetal derivado de esteroide.

Country Status (25)

Country Link
US (2) US5955622A (es)
EP (1) EP0776904B1 (es)
JP (1) JP3984315B2 (es)
KR (1) KR100430312B1 (es)
CN (1) CN1152847C (es)
AR (1) AR004813A1 (es)
AT (1) ATE190314T1 (es)
AU (1) AU713688B2 (es)
CA (1) CA2191397C (es)
CZ (1) CZ293396B6 (es)
DE (1) DE69606957T2 (es)
DK (1) DK0776904T3 (es)
ES (1) ES2145971T3 (es)
GR (1) GR3033527T3 (es)
HU (1) HUP9603296A3 (es)
IL (1) IL119649A (es)
IN (1) IN182807B (es)
MX (1) MX9605981A (es)
NO (1) NO307887B1 (es)
NZ (1) NZ299836A (es)
PL (1) PL185112B1 (es)
PT (1) PT776904E (es)
RU (1) RU2165430C2 (es)
TR (1) TR199600944A1 (es)
ZA (1) ZA969778B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611909A (en) * 2004-08-04 2006-04-16 Akzo Nobel Nv Process for the preparation 2-substituted-derivatives of estrone and estradiol
TW200613316A (en) 2004-08-26 2006-05-01 Akzo Nobel Nv Process for the preparation of estrone and/or estradiol-derivates
HUP0501132A2 (en) 2005-12-05 2007-06-28 Richter Gedeon Nyrt 17-alpha-cyanomethyl-17betha-hydroxyestra-4,9-diene-3-one of high purity and process for its production
ITMI20062504A1 (it) 2006-12-22 2008-06-23 Antibioticos Spa Procedimento per la preparazione di 17alfa-cianometil-17beta-idrossi steroidi
US8673968B2 (en) * 2009-04-06 2014-03-18 Evestra, Inc. Progesterone antagonists
US20130041166A1 (en) 2010-04-20 2013-02-14 Lupin Limited Process for the preparation of dienogest substantially free of impurities
CN101863947A (zh) * 2010-06-29 2010-10-20 沈阳药科大学 一种地诺孕素的合成方法
CN102718828A (zh) * 2011-03-30 2012-10-10 西藏海思科药业集团股份有限公司 一种地诺孕素的制备方法
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists
CN104497088B (zh) * 2014-12-30 2016-08-24 湖南新合新生物医药有限公司 19-去甲-4-雄甾烯-3,17-二酮的制备方法
CN108997463B (zh) * 2018-08-09 2021-05-14 四川理工学院 一种雌甾-4，9-二烯-3，17-二酮制备方法
CN112409434B (zh) * 2020-11-27 2021-10-26 厦门欧瑞捷生物科技有限公司 一种去氢孕酮的合成方法
CN113861158B (zh) * 2021-11-22 2023-02-10 湖南新合新生物医药有限公司 一种合成甲基双烯双酮关键中间体的方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114456223B (zh) * 2022-01-24 2023-07-21 湖南科益新生物医药有限公司 3-缩酮的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632347A (es) *
DE296931C (es) 1915-11-05 1917-03-06
NL123143C (es) * 1962-03-06
NL127071C (es) * 1964-12-31
FR2201287A1 (en) * 1972-09-27 1974-04-26 Roussel Uclaf Epoxidation using hexafluoroacetone hydroperoxide - for treatment of unsatd. cyclic cpds esp steroids
DE3113053A1 (de) * 1981-04-01 1982-10-21 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung eines tricyclischen steroid-abbauprodukts
US4400524A (en) * 1981-07-28 1983-08-23 The Upjohn Company Grignard reagents prepared from 5-halopentan-2-one propylene ketals
DE3208432A1 (de) * 1982-03-09 1983-09-15 The Upjohn Co., 49001 Kalamazoo, Mich. Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung
HU201091B (en) * 1985-12-26 1990-09-28 Mitsubishi Chem Ind Process for producing gonatriene derivatives and pharmaceutical compositions comprising same
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
CA2086919C (en) * 1990-07-09 1998-02-24 Gerhard Teichmuller Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
ES2124905T3 (es) * 1993-08-04 1999-02-16 Akzo Nobel Nv Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.

Also Published As

Publication number Publication date
GR3033527T3 (en) 2000-09-29
MX9605981A (es) 1998-04-30
CA2191397A1 (en) 1997-05-31
EP0776904A3 (en) 1997-12-17
JP3984315B2 (ja) 2007-10-03
KR100430312B1 (ko) 2004-07-30
US5955622A (en) 1999-09-21
IL119649A (en) 2002-03-10
NO965113D0 (no) 1996-11-29
CZ350496A3 (cs) 1998-03-18
DK0776904T3 (da) 2000-07-31
US6005124A (en) 1999-12-21
IN182807B (es) 1999-04-24
TR199600944A1 (tr) 1997-06-21
ZA969778B (en) 1997-06-17
EP0776904A2 (en) 1997-06-04
AU7404196A (en) 1997-06-05
CZ293396B6 (cs) 2004-04-14
AR004813A1 (es) 1999-03-10
NO965113L (no) 1997-06-02
PL185112B1 (pl) 2003-02-28
CN1168876A (zh) 1997-12-31
IL119649A0 (en) 1997-02-18
JPH09183792A (ja) 1997-07-15
PL317248A1 (en) 1997-06-09
CN1152847C (zh) 2004-06-09
HUP9603296A3 (en) 1998-07-28
EP0776904B1 (en) 2000-03-08
NO307887B1 (no) 2000-06-13
ATE190314T1 (de) 2000-03-15
DE69606957T2 (de) 2000-10-05
KR970027102A (ko) 1997-06-24
PT776904E (pt) 2000-07-31
DE69606957D1 (de) 2000-04-13
HU9603296D0 (en) 1997-01-28
RU2165430C2 (ru) 2001-04-20
NZ299836A (en) 1997-11-24
HUP9603296A2 (en) 1997-08-28
CA2191397C (en) 2006-08-01
AU713688B2 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
ES2145971T3 (es) Procedimiento de preparacion de un cetal derivado de esteroide.
KR950002755A (ko) 워트마닌 및 그의 유사체에 의한 포스파티딜이노시톨 3-키나제의 억제
KR900006318A (ko) 피페리디닐 벤즈이미다졸
CA2081299A1 (en) Foaming agent composition and process
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
KR880000400A (ko) 융합된 사이클릭 아제핀-2-온 유도체 및 그의 제조방법
NO175617C (no) Fremgangsmåte ved fremstilling av blandinger som omfatter vandig etanol, for ökning av transdermal ström
AU2251901A (en) Methods and compounds for inhibiting MRP1
DE60118198D1 (de) Fettsäure-analoge zur behandlung von krebs
BR8802021A (pt) Agentes repelentes de insetos e de acaros,processos para o combate a insetos e acaros e para a preparacao de agentes derivados e processo para sua preparacao
EA199800013A1 (ru) Способы минимизации остеопороза
CA2458318A1 (en) Wortmannin analogs and methods of using same
RU94045799A (ru) СПОСОБ ПОЛУЧЕНИЯ β-ФЕНИЛИЗОСЕРИНА И ЕГО АНАЛОГОВ, СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ТАКСАНА И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ СИНТЕЗА
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
KR920004348A (ko) (벤즈히드릴옥시에틸피페리딜)지방족 산 유도체 및 알러지와 천식의 치료에 있어서의 그의 용도
JPS56150002A (en) Nonaprenylamine derivative
ES2182317T3 (es) Produccion de compuestos de avermectina.
AR004666A1 (es) Etilamido fluoreno, con propiedades melatonergicas y composicion farmaceutica que lo contiene
BR0015122A (pt) Composição farmacêutica, e, método de tratamento de inflamação
AR016733A1 (es) Procedimiento de preparacion de 4-(3-piridinil)-1h-imidazol, y los compuestos intermedios empleados
EA200100039A1 (ru) Способы увеличения уровней ацетилхолина
KR930703013A (ko) 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제
BR0012599A (pt) Método para preparação de debromohimenialdisina e análogos desta
ES2104039T3 (es) Procedimiento de estabilizacion de un hidrofluoroalcano y composiciones que comprenden al menos un hidrofluoroalcano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 776904

Country of ref document: ES